206 related articles for article (PubMed ID: 3262057)
1. The role of beta-hydroxyaspartate and adjacent carboxylate residues in the first EGF domain of human factor IX.
Rees DJ; Jones IM; Handford PA; Walter SJ; Esnouf MP; Smith KJ; Brownlee GG
EMBO J; 1988 Jul; 7(7):2053-61. PubMed ID: 3262057
[TBL] [Abstract][Full Text] [Related]
2. Ca2+ binding to the first epidermal growth factor-like domain of human blood coagulation factor IX promotes enzyme activity and factor VIII light chain binding.
Lenting PJ; Christophe OD; Maat H; Rees DJ; Mertens K
J Biol Chem; 1996 Oct; 271(41):25332-7. PubMed ID: 8810297
[TBL] [Abstract][Full Text] [Related]
3. Baculovirus-mediated expression of the epidermal growth factor-like modules of human factor IX fused to the factor XIIIa transamidation site in fibronectin. Evidence for a direct interaction between the NH2-terminal epidermal growth factor-like module of factor IXa beta and factor X.
Astermark J; Sottile J; Mosher DF; Stenflo J
J Biol Chem; 1994 Feb; 269(5):3690-7. PubMed ID: 7906269
[TBL] [Abstract][Full Text] [Related]
4. Construction, expression, and characterization of a chimera of factor IX and factor X. The role of the second epidermal growth factor domain and serine protease domain in factor Va binding.
Hertzberg MS; Ben-Tal O; Furie B; Furie BC
J Biol Chem; 1992 Jul; 267(21):14759-66. PubMed ID: 1634519
[TBL] [Abstract][Full Text] [Related]
5. Hydrophobic contact between the two epidermal growth factor-like domains of blood coagulation factor IX contributes to enzymatic activity.
Celie PH; Lenting PJ; Mertens K
J Biol Chem; 2000 Jan; 275(1):229-34. PubMed ID: 10617609
[TBL] [Abstract][Full Text] [Related]
6. The gamma-carboxyglutamic acid and epidermal growth factor-like modules of factor IXa beta. Effects on the serine protease module and factor X activation.
Astermark J; Hogg PJ; Stenflo J
J Biol Chem; 1994 Feb; 269(5):3682-9. PubMed ID: 8106413
[TBL] [Abstract][Full Text] [Related]
7. Blood coagulation factor IX residues Glu78 and Arg94 provide a link between both epidermal growth factor-like domains that is crucial in the interaction with factor VIII light chain.
Christophe OD; Lenting PJ; Kolkman JA; Brownlee GG; Mertens K
J Biol Chem; 1998 Jan; 273(1):222-7. PubMed ID: 9417068
[TBL] [Abstract][Full Text] [Related]
8. Effect of propeptide mutations on post-translational processing of factor IX. Evidence that beta-hydroxylation and gamma-carboxylation are independent events.
Rabiet MJ; Jorgensen MJ; Furie B; Furie BC
J Biol Chem; 1987 Nov; 262(31):14895-8. PubMed ID: 3667614
[TBL] [Abstract][Full Text] [Related]
9. Factor IXHollywood: substitution of Pro55 by Ala in the first epidermal growth factor-like domain.
Spitzer SG; Kuppuswamy MN; Saini R; Kasper CK; Birktoft JJ; Bajaj SP
Blood; 1990 Oct; 76(8):1530-7. PubMed ID: 2169923
[TBL] [Abstract][Full Text] [Related]
10. Tyrosine 69 of the first epidermal growth factor-like domain of human factor IX is essential for clotting activity.
Hughes PE; Morgan G; Rooney EK; Brownlee GG; Handford P
J Biol Chem; 1993 Aug; 268(24):17727-33. PubMed ID: 8349658
[TBL] [Abstract][Full Text] [Related]
11. Expression and characterization of human factor IX and factor IX-factor X chimeras in mouse C127 cells.
Lin SW; Smith KJ; Welsch D; Stafford DW
J Biol Chem; 1990 Jan; 265(1):144-50. PubMed ID: 2294100
[TBL] [Abstract][Full Text] [Related]
12. Factor IX Fukuoka. Substitution of ASN92 by His in the second epidermal growth factor-like domain results in defective interaction with factors VIIa/X.
Nishimura H; Takeya H; Miyata T; Suehiro K; Okamura T; Niho Y; Iwanaga S
J Biol Chem; 1993 Nov; 268(32):24041-6. PubMed ID: 8226948
[TBL] [Abstract][Full Text] [Related]
13. The first EGF-like domain from human factor IX contains a high-affinity calcium binding site.
Handford PA; Baron M; Mayhew M; Willis A; Beesley T; Brownlee GG; Campbell ID
EMBO J; 1990 Feb; 9(2):475-80. PubMed ID: 2406129
[TBL] [Abstract][Full Text] [Related]
14. Protein engineering of the hydrophobic domain of human factor IX.
Hughes PE; Handford PA; Austen DE; Brownlee GG
Protein Eng; 1994 Sep; 7(9):1121-7. PubMed ID: 7831283
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the functional defect in factor IX Alabama. Evidence for a conformational change due to high affinity calcium binding in the first epidermal growth factor domain.
McCord DM; Monroe DM; Smith KJ; Roberts HR
J Biol Chem; 1990 Jun; 265(18):10250-4. PubMed ID: 2355000
[TBL] [Abstract][Full Text] [Related]
16. A moderate form of hemophilia B is caused by a novel mutation in the protease domain of factor IXVancouver.
Geddes VA; Le Bonniec BF; Louie GV; Brayer GD; Thompson AR; MacGillivray RT
J Biol Chem; 1989 Mar; 264(8):4689-97. PubMed ID: 2494175
[TBL] [Abstract][Full Text] [Related]
17. The epidermal growth factor-like domains of factor IX. Effect on blood clotting and endothelial cell binding of a fragment containing the epidermal growth factor-like domains linked to the gamma-carboxyglutamic acid region.
Astermark J; Stenflo J
J Biol Chem; 1991 Feb; 266(4):2438-43. PubMed ID: 1989995
[TBL] [Abstract][Full Text] [Related]
18. Replacing the first epidermal growth factor-like domain of factor IX with that of factor VII enhances activity in vitro and in canine hemophilia B.
Chang JY; Monroe DM; Stafford DW; Brinkhous KM; Roberts HR
J Clin Invest; 1997 Aug; 100(4):886-92. PubMed ID: 9259588
[TBL] [Abstract][Full Text] [Related]
19. Calcium binding to a human factor IXa derivative lacking gamma-carboxyglutamic acid: evidence for two high-affinity sites that do not involve beta-hydroxyaspartic acid.
Morita T; Kisiel W
Biochem Biophys Res Commun; 1985 Jul; 130(2):841-7. PubMed ID: 3875344
[TBL] [Abstract][Full Text] [Related]
20. The distinct roles that Gln-192 and Glu-217 of factor IX play in selectivity for macromolecular substrates and inhibitors.
Hsu YC; Hamaguchi N; Chang YJ; Lin SW
Biochemistry; 2001 Sep; 40(37):11261-9. PubMed ID: 11551226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
